Esther Schlossberg, BA
Project CoordinatorCards
Contact Info
About
Titles
Project Coordinator
Biography
Esther is a Project Coordinator for InSTRIDE working on research involving substance use disorders and infectious diseases. Previously, she worked as the Postgraduate Research Associate for InSTRIDE. She graduated in May 2020 with degrees in Public Health and Jewish Studies from Muhlenberg College in Allentown, PA. During college, she interned at the Connecticut Department of Public Health for the Office of Injury Prevention, Community, Family Health, and Prevention Section, where she worked on a statewide public awareness campaign to help communities deal with the prescription drug and opioids misuse crisis and assisted with the creation of an opioid overdose app specific to Connecticut. Additionally, she interned at St. Luke’s University Health Network in Allentown, PA where she worked on projects centered around opioid prevention and recovery. Also, she worked as Head Narcan Trainer for the “End Overdose Together” initiative where she assured community trainers were well-educated on how to administer Narcan and on the scale and scope of the opioid crisis in the Lehigh Valley. Esther is interested in public health, infectious diseases, substance use disorders, justice-system involvement, community health, and the opioid epidemic. She hopes to work in positions throughout her career that help people and that lead towards making positive changes in the health for all people.
Departments & Organizations
Education & Training
- BA
- Muhlenberg College, Public Health (2020)
Research
Research at a Glance
Yale Co-Authors
Sandra Ann Springer, MD
Albert C Shaw, MD, PhD
Angela Di Paola, PhD
Brent Vander Wyk, PhD
Publications
2022
Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons
Springer SA, Nijhawan AE, Knight K, Kuo I, Di Paola A, Schlossberg E, Frank CA, Sanchez M, Pankow J, Proffitt RP, Lehman W, Pulitzer Z, Thompson K, Violette S, Harding KK. Study protocol of a randomized controlled trial comparing two linkage models for HIV prevention and treatment in justice-involved persons. BMC Infectious Diseases 2022, 22: 380. PMID: 35428213, PMCID: PMC9013109, DOI: 10.1186/s12879-022-07354-x.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsJustice-involved individualsAntiretroviral treatmentHIV preventionUse disordersStudy participantsStimulant useSubstance use disorder servicesCommunity-based HIVPost-release interventionsPrimary implementation outcomeHIV viral loadPre-exposure prophylaxisOpioid use disorderTreatment of HIVHIV risk behaviorsRisk of HIVSubstance use disordersHigh-risk communitiesHybrid type 1Justice-involved personsHCV testingLinkage interventionHIV careSecondary outcomesART adherenceFactors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community
Biondi BE, Vander Wyk B, Schlossberg EF, Shaw A, Springer SA. Factors associated with retention on medications for opioid use disorder among a cohort of adults seeking treatment in the community. Addiction Science & Clinical Practice 2022, 17: 15. PMID: 35255967, PMCID: PMC8899775, DOI: 10.1186/s13722-022-00299-1.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsOpioid use disorderHigher pain interferenceMOUD retentionPain interferenceUse disordersOngoing prospective cohort studySevere opioid use disorderProspective cohort studyMultivariable logistic regressionCohort of adultsMethadone doseAnalgesic effectBuprenorphine doseCohort studyOpioid useResultsA totalHigher oddsMOUDAdjusted modelHigh doseLogistic regressionBuprenorphineMethadoneDoseDiscontinuation
2021
Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions
Taweh N, Schlossberg E, Frank C, Nijhawan A, Kuo I, Knight K, Springer SA. Linking criminal justice-involved individuals to HIV, Hepatitis C, and opioid use disorder prevention and treatment services upon release to the community: Progress, gaps, and future directions. International Journal Of Drug Policy 2021, 96: 103283. PMID: 34020864, PMCID: PMC8568621, DOI: 10.1016/j.drugpo.2021.103283.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsMobile health unitOpioid use disorderHepatitis COUD preventionTreatment servicesInfectious diseasesHepatitis C virus (HCV) managementOpioid use disorder preventionCJ-involved individualsCriminal justice-involved individualsCJ systemHarm reduction servicesImproving HIVCare cascadePatient navigationJustice-involved individualsHealth unitsUse disordersHIVReduction servicesSubstance usePreventionDisorder preventionCommunity agenciesTreatment